Purchases and Sales Made in Q3 2022 in Salarius Pharmaceuticals, Inc. (SLRX)
This table provides information about the institutional ownership of Salarius Pharmaceuticals, Inc. (SLRX) during Q3 2022. The information is specifically focused on institutions that hold shares of Salarius Pharmaceuticals, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 14, 2022
Q3 2022
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
96.2K+ 17.88% |
$16.4K - $3.98M
|
634K
$1.17M
|
|
Nov 14, 2022
Q3 2022
|
Horizon Kinetics Asset Management LLC
|
BUY
|
- |
20K+ 50.0% |
$3.4K - $827K
|
60K
$111K
|
|
Nov 14, 2022
Q3 2022
|
Morgan Stanley
New York, NY |
BUY
|
- |
2+ 0.13% |
$0.34 - $82.7
|
1.5K
$2.78K
|
|
Nov 15, 2022
Q3 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Nov 14, 2022
Q3 2022
|
Commonwealth Equity Services, LLC
|
SELL
|
- |
-2- 0.02% |
$0.34 - $82.7
|
12.4K
$22.9K
|
|
Nov 14, 2022
Q3 2022
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
SELL
|
- |
-4- 0.01% |
$0.68 - $165
|
34.7K
$64.2K
|
|
Nov 14, 2022
Q3 2022
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-25- 6.67% |
$4.25 - $1.03K
|
350
$648
|
|
Nov 10, 2022
Q3 2022
|
Ubs Group Ag
|
SELL
|
- |
-1.44K- 3.4% |
$244 - $59.4K
|
40.8K
$75.6K
|
|
Nov 14, 2022
Q3 2022
|
Two Sigma Securities, LLC
New York, NY |
SELL
|
- |
-3.31K- 21.35% |
$562 - $137K
|
12.2K
$22.5K
|
|
Nov 14, 2022
Q3 2022
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-16.2K- 4.97% |
$2.75K - $670K
|
310K
$574K
|
|
Nov 10, 2022
Q3 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-55.1K- 69.59% |
$9.37K - $2.28M
|
24.1K
$44.6K
|
|
Nov 14, 2022
Q3 2022
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-176K- 60.37% |
$30K - $7.28M
|
116K
$214K
|
|
Nov 14, 2022
Q3 2022
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-232K- 14.61% |
$39.4K - $9.58M
|
1.35M
$2.5M
|